Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D

Zoledronic acid (Zol) is a widely used intravenous aminobisphosphonate to treat both benign and malignant skeletal diseases, and bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious side effect whose pathophysiology remains poorly understood. Vascular Endothelial Growth Factor (VEGF)...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Federica Bellone, Antonino Catalano, Angelo Ruggero Sottile, Agostino Gaudio, Saverio Loddo, Francesco Corica, Nunziata Morabito
स्वरूप: लेख
भाषा:English
प्रकाशित: Frontiers Media S.A. 2021-11-01
श्रृंखला:Frontiers in Medicine
विषय:
ऑनलाइन पहुंच:https://www.frontiersin.org/articles/10.3389/fmed.2021.748438/full